Průběh V Diagnóza A Léčba Z Primární Chronická ZácpaⅢ

Nelék léčba je první léčba pro zácpu. Pokud účinek je ne významný, lék léčba může být zvažován. Mezi nimi, anorektální biofeedback terapie má a významný účinek na pacienti s defekací dyssynergií. At současnost, mikroekologická terapie má stal stal účinný a populární léčba metoda pro léčbu léčba primární chronická zácpa a má a dobrý vývoj vyhlídka. Chirurgické léčba je také a konečná léčba strategie pro zácpu pacienti s závažný příznaky kdo selhat konzervativní léčba, nebo kdo splnit indikace pro operaci.

Click k Cistanche pro home opravné prostředky pro zácpu

(1) Nelék Léčba

1. Modification of diet and lifestyle: Modification of diet and lifestyle is often used as a first-line treatment strategy for patients with chronic constipation. The effectiveness of this approach is based on epidemiological studies linking constipation to various dietary and lifestyle factors, such as low dietary fiber intake, low fluid intake, and physical inactivity. Mechanisms driving the laxative effect of dietary fiber vary: large or coarse insoluble fiber particles (eg, bran) mechanically stimulate the intestinal mucosa, stimulating water and mucus secretion; gel-forming soluble fibers (eg, fungus, pectin) have High water retention capacity, can resist dehydration, and transport water to the colon to loosen the consistency of stool [15]. Although increasing fluid intake is often recommended to improve symptoms in people with constipation, there is no evidence or controlled trials that increasing fluid intake is effective in treating constipation. Increasing physical activity in young patients with severe constipation does little to help relieve constipation [1]. In elderly patients with significant physical inactivity, increasing physical activity as part of an overall rehabilitation program may be beneficial for constipation.

2. Anorektální biofeedback terapie% 3a Anorektální biofeedback terapie je více účinný než nelék léčba (životní styl úpravy), projímadla, nebo anti-úzkost lék diazepam pro pacienty s defekací dyssynergií , s dobrou dlouhodobou výsledky , to může být použito jako první volba pro léčbu defekaci syndrom %% 5b16% 5d. Sedmdesát procent z pacientů odpověděl na biofeedback terapie, která byl hodnocena jako a stupeň A doporučení podle americká a evropská společnost z neurogastroenterologie a kinetika.

(2) Lék léčba

Drogy v současné době schválené pro léčbu z zácpy hlavně zahrnují osmotické projímadla, stimulanty projímadla, sekretagogy, a serotonin (5-HT) receptor agonisté.

1. osmotická projímadla: pro pacienty s chronickou zácpou kdo ano ne reagovat na dietu a životní styl změny , osmotická projímadla například jako polyethylen glykol a laktulóza jsou další společná léčba. osmotická projímadla může příčina an osmotický gradient v střevní lumen % 2c vedoucí k sekreci vodě a elektrolytům do střeva lumen % 2c tím snížení stolice konzistence a zvýšení stolice objem % 5b17% 5d. osmotické projímadlo polyethylen glykol bylo bylo testováno v několik vysoce kvalitní randomizované kontrolované pokusy trvalé a a ukázalo zlepšení v příznaky chronické zácpa ve srovnání s placebem %[18]. Cíl použití osmotické laxativa je k zlepšit pacient's primární příznaky. bakteriální metabolismus z nevstřebaný sacharidy může vést k plynu a břicho křeče, který může může omezit dlouhodobé použití z osmotické Projímadla [19].

2. Stimulant laxatives: If the curative effect of osmotic laxatives is not significant, stimulant laxatives can be selected for treatment. Stimulant laxatives induce the secretion of water and electrolytes, stimulate intestinal motility, release prostaglandins, and accelerate colonic transit [20]. Stimulant laxatives, including diphenylmethane derivatives (bisacodyl and sodium picosulfate) and anthraquinone derivatives (senna leaf, aloe vera), are often used in patients with acute symptoms, such as for 2–3 days without Defecation patients [19]. A study evaluating the efficacy of various stimulant laxatives for constipation found that bisacodyl was superior to sodium picosulfate, prucalopride, and lubiprost in eliciting more than 3 completely spontaneous bowel movements per week Other drugs such as ketones and linaclotide [21]. Senna is also commonly used in the treatment of chronic constipation, but there are currently no placebo-controlled trials evaluating its efficacy. There are few long-term studies or comparisons of stimulant laxatives with other drugs, and their use is often limited by adverse effects of abdominal pain and diarrhea. Clinical trials have shown that stimulant laxatives are resistant and less effective after long-term use.

3. Secretagogues: If the patient does not respond to conventional laxatives, secretagogues can be tried. Currently available secretagogues (such as lubiprostone, linaclotide, and procainamide) work by direct action Treat constipation by increasing fluid secretion in the intestinal lumen from the intestinal epithelium. Lubiprostone does this by activating chloride channels on luminal epithelial cells, while linaclotide and procainamide are guanylate cyclase C receptor agonists that increase intestinal epithelial cGMP, eventually leading to the opening of the cystic fibrosis transmembrane conductance regulator chloride ion channel [22]. Li et al [23] conducted a meta-analysis, summarizing 9 randomized controlled trials of lubiprostone and placebo, and found that the frequency of stool increased and the severity of constipation was significantly improved after 4 weeks of use of lubiprostone, and reduced fatigue and bloating, and overall constipation relief. Nausea is the most common adverse reaction of lubiprostone [24]. Linaclotide can improve intestinal and abdominal symptoms in patients with chronic constipation accompanied by moderate to severe abdominal distension, and diarrhea is the most common adverse reaction of taking linaclotide [25]. The efficacy of procainamide is similar to that of linaclotide [26].

4. 5-HT4 receptor agonists: Prucalopride is a highly selective 5-HT4 receptor agonist that activates afferent neuronal signals to increase gut motility. A meta-analysis of six phase III and IV randomized controlled trials showed that, compared with placebo, after 12 weeks of treatment with prucalopride 2 mg once daily, more patients with constipation had an average of 3 times or more spontaneous defecation[27]. Prucalopride was well tolerated, with no substantial cardiovascular effects or drug interactions, and the most common adverse reactions were gastrointestinal disturbances (such as diarrhea, nausea, and abdominal pain) and headache. Velukast and nanofibril, like prucalopride, are selective 5-HT4 receptor agonists with prokinetic effects. These drugs have shown promise in phase II clinical trials but have not been further evaluated. Table 1 summarizes the current medications commonly used in the treatment of chronic constipation.

(3) Mikroekologické ošetření

V nedávné roky, studie na střevní nemoci a střevní flóra mají odhalily vztah mezi chronický zácpa a střevní flóra poruchy a poskytnuté a teoretický základ pro mikroekologická léčba chronická zácpa. dané jejich široké role v různé gastrointestinální a negastrointestinální nemoci, mikrobiom terapie se stal a populární terapeutický přístup mezi potenciální terapeutické léky. Mikrobiální terapie Hlavně zahrnuje Probiotika, Prebiotika, Synbiotika, Postbiotika, antibiotika, a flóra transplantace.

1. Probiotics: Lactobacillus and Bifidobacteria are commonly used as probiotics to treat constipation. Almost all studies of probiotics for constipation in adults have shown the effectiveness of probiotics. Dimidi et al [28] found that changing the intestinal environment with certain probiotic strains may affect intestinal motility and secretion, thereby benefiting patients with constipation. In addition, probiotics can relieve constipation and improve other symptoms caused by constipation. For example, probiotics protect neurons by activating protein kinase signaling pathways, thereby alleviating constipation-induced depression [29]. However, simple supplementation of probiotics does not necessarily change the human intestinal mucosal flora. Due to host specificity, probiotics and intestinal flora have different intestinal mucosal colonization resistance among different hosts[30 ], which may affect the function of probiotics. For example, Russo et al. [31] conducted a study on the effect of probiotics on children with constipation. Compared with polyethylene glycol alone, polyethylene glycol + probiotics did not significantly improve the efficacy.

2. Prebiotika: Prebiotika patřit k a druh z nestravitelné sacharidy, takové jako oligosacharidy a inulin, který může zvýšit počet běžné probiotika v lidské těle, takové jako jako bifidobakterie a laktobacily, tím zlepšením zácpa příznaky. V současné době, dostupný prebiotika zahrnuje lidské mléko oligosacharidy, laktulóza, a inulin deriváty. Huang et al [32] použité laktulóza k léčit pacienti s poporodní zácpa a nalezeno že zlepšení zácpa příznaky bylo výrazně lepší než to to z kontrola skupina, včetně zvýšené úleva čas, prodloužené bez zácpy dny, a snížené defekace čas.

3. Synbiotics: Synbiotics are biological preparations used in combination with probiotics and prebiotics, which are characterized by the simultaneous action of probiotics and prebiotics. Synbiotics can effectively regulate intestinal flora, and improve stool frequency, stool consistency, and constipation-related symptoms [33]. Bazzocchi et al. [34] did a study on the treatment of constipation with synbiotics. They gave synbiotics and maltodextrin (placebo) treatment for 8 weeks, and the results showed that patients receiving synbiotics had significant improvements in bowel movement frequency and stool consistency. In addition, the colonic transit time of the synbiotic group was significantly shortened, and 5 types of lactobacillus effective in improving constipation were found in the stool samples of half of the patients in the synbiotic group, including Lactobacillus planetarium, Lactobacillus acidophilus, and Lactobacillus rhamnosus. In the above studies, adverse reactions including abdominal pain, abdominal distension, nausea, and vomiting rarely occurred. Therefore, probiotics, prebiotics, and synbiotics may be effective options for the treatment of constipation.

4. Postbiotics: In 2019, the International Probiotics and Prebiotics Scientific Association made a clear definition of postbiotics: postbiotics are preparations of non-living microorganisms and/or their components that are beneficial to the health of the host [35]. Intestinal flora can affect the host by secreting small molecules that regulate host cell and body functions, such as indole and its derivatives, and short-chain fatty acids. These small molecules are efficient means of communication in host-microbe interactions. Based on these metabolites, postbiotics can target downstream signaling pathways that regulate the microbiota and work by mitigating the negative effects of excess, scarcity, or dysregulation of metabolites involved in these pathways [36]. One of the disadvantages of using postbiotics for treatment is that the half-life is shorter than using live bacteria and, therefore, repeated dosing may be required to treat disorders associated with the disorder. Furthermore, due to the pleiotropic and cell-type specificity of the actions of some microbiota-associated metabolites, it is necessary to further explore the full physiological roles of different metabolites. The efficacy of postbiotics in the treatment of chronic constipation remains to be studied, but this metabolite-based therapeutic strategy is very promising.

5. Antibiotika: Předchozí studie mají navrhují a souvislost mezi zácpa a metanogenní bakterie, a metanogenní střevní mikrobiota plechovka olovo k zácpa podle snížení defekace [37]. Ačkoli některé studie mají prokázaly že antibiotika mohou být použit k léčit zácpa, to je není hlavní účel z klinické použití antibiotika.

6. Fecal microbiota transplantation (FMT): FMT is the transfer of the entire microbial community from a healthy donor to the patient's gut to replace the disease-associated microbiome. FMT is effective in the treatment of Clostridium difficile infection [38]. The feasibility of FMT in the treatment of chronic constipation has been reported by many studies. Tian et al [39] conducted a randomized controlled trial, in which 60 patients with STC were divided into an FMT group or control group, and received conventional laxative treatment. The results showed that patients who received FMT experienced significant improvements in constipation symptoms, including bowel movement frequency and stool quality. Despite the small sample size, they demonstrated that FMT is effective in treating constipation. However, because of donor selection and cost and complexity, FMT is unlikely to be considered a first choice. FMT should be used selectively in patients who are insensitive to conventional treatment strategies.

(4) chirurgické ošetření

Chirurgická léčba z zácpa je zřídka indikováno a vyžaduje přísná kritéria. Chirurgie je pouze indikováno pro pacienty s STC a ne pro pacienty s pánev dno dysfunkce vedoucí k nekoordinované střevo pohyby nebo zácpa-převládající podrážděné střevo. V pacienti s kombinovaná defekace dyssynergie a STC, pánev patro dysfunkce musí být opraveno před chirurgické intervence stane an možnost [40].

Surgical options for slow transit constipation include ileostomy, total colectomy with ileorectal anastomosis, antegrade cecostomy, rectocele, recto intussusception and rectal mucosal prolapse repair, sacral nerve stimulation [41 ]. Psychiatric consultation should be actively considered before total colectomy and ileorectal anastomosis in patients with STC and defecation dyssynergia, but the use of colectomy with ileorectal anastomosis rather than ileorectal anastomosis alone for constipation is controversial. Patients with STC and defecation inconsistency may benefit from total colectomy if pelvic floor dysfunction is corrected first. In the presence of severe, uncorrectable pelvic floor dysfunction, the only surgery that can relieve symptoms is a terminal ileostomy. Anterograde jejunostomy is preferred in children with chronic refractory constipation. Sacral neuromodulation therapy is considered to be an experimental therapy for the treatment of chronic constipation in adults. Domestic studies have shown that this therapy has a significant effect on STC, and has the advantages of safety and easy operation[42].

Although primary chronic constipation is a digestive system disease, it is often combined with mental and psychological disorders. Lack of attention to constipation and drug abuse are important factors leading to recurrence and even worsening of the course of the disease. Diagnosis and treatment of constipation is a complicated process. Accurate diagnosis of constipation subtypes is the basis for effective treatment of constipation. At the same time, it is very important to use therapeutic drugs or strategies rationally and standardized according to the clinical symptoms and severity of patients. This requires a more professional clinical team. At present, the drugs and strategies for the treatment of constipation are constantly improving, and the emerging microecological treatment is booming. However, there are still many problems, such as the pathophysiological mechanism of each subtype of constipation is still unclear, and its diagnosis and treatment level still need to be improved. In recent years, the proposal of the gut-brain-microbiota axis has revealed new ideas for exploration, suggesting that gut microbiota may be a potential therapeutic target for constipation in the future.

Přírodní bylinné léky pro úlevu zácpu - cistanche% c2% a0

Cistanche is a genus of parasitic plants that belongs to the family Orobanchaceae. These plants are known for their medicinal properties and have been used in Traditional Chinese Medicine (TCM) for centuries. Cistanche species are predominantly found in arid and desert regions of China, Mongolia, and other parts of Central Asia. Cistanche plants are characterized by their fleshy, yellowish stems and are highly valued for their potential health benefits. In TCM, Cistanche is believed to have tonic properties and is commonly used to nourish the kidney, enhance vitality, and support sexual function. It is also used to address issues related to aging, fatigue, and overall well-being. While Cistanche has a long history of use in traditional medicine, scientific research on its efficacy and safety is ongoing and limited. However, it is known to contain various bioactive compounds such as phenylethanoid glycosides, iridoids, lignans, and polysaccharides, which may contribute to its medicinal effects.

Wecistanche's cistanche prášek, cistanche tabletky, cistanche Kapsle, a ostatní produkty jsou vyvinuté použití poušť cistanche jako sura materiály, vše z který mají a dobrý účinek na úleva zácpa. specifický mechanismus je jako následující: Cistanche je věří k mít potenciál přínosy pro úlevu zácpu založený jeho tradiční použití a určité sloučeniny to obsahuje. Zatímco vědecký výzkum konkrétně na Cistanche's účinek na zácpa je omezený, to je myšlenka k mít násobek mechanismy že může přispět k svému potenciál k úlevě zácpa. Projímadlo Účinek: Cistanche has long been used in Traditional Chinese Medicine as a remedy for constipation. It is believed to have a mild laxative effect, which can help promote bowel movements and induce constipation. This effect may be attributed to various compounds found in Cistanche, such as phenylethanoid glycosides and polysaccharides. Moistening the Intestines: Based on traditional use, Cistanche is considered to have moisturizing properties, specifically targeting the Intestines. By promoting hydration and lubrication of the Intestines, it may help soften tools and facilitate easier passage, thereby relieving constipation. Anti-inflammatory Effect: Constipation can sometimes be associated with inflammation in the digestive tract. Cistanche contains certain compounds, including phenylethanoid glycosides and lignans, that are believed to have anti-inflammatory properties. By reducing inflammation in the intestines, it may help improve bowel movement regularity and relieve constipation.